Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity
Xiaohan Shi, Yunguang Li, Qiuyue Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Human organoids-on-chips for biomedical research and applications
Hui Wang, Xiufan Ning, Feng Zhao, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 788-818
Open Access | Times Cited: 23
Construction of tumor organoids and their application to cancer research and therapy
Jiajing Lv, Xuan Du, Miaomiao Wang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1101-1125
Open Access | Times Cited: 21
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
Lucie Thorel, Marion Perréard, Romane Florent, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1531-1551
Open Access | Times Cited: 21
Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
Yunguang Li, Shijie Tang, Xiaohan Shi, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101162-101162
Open Access | Times Cited: 29
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Dongxi Xiang, Aina He, Rong Zhou, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3300-3316
Open Access | Times Cited: 14
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer
Alice Boilève, Jérôme Cartry, Negaar Goudarzi, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 961-976.e13
Open Access | Times Cited: 13
A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options
Lulu Sun, Xindan Kang, Houyu Ju, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 17
Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer
Yifan Fu, Jinxin Tao, Yani Gu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Transcriptomic subtyping of gastrointestinal malignancies
Tim R. de Back, Sander R. van Hooff, Dirkje W. Sommeijer, et al.
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 842-856
Open Access | Times Cited: 7
CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression
Yujun Shuai, Hui Zhang, Changhao Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens
Hao Chi, Lanqian Su, Yalan Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Advancing cancer research through organoid technology
Zeng Ge, Yifan Yu, Meiting Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Clinical functional proteomics of intercellular signalling in pancreatic cancer
Peiwu Huang, Weina Gao, Changying Fu, et al.
Nature (2024)
Closed Access | Times Cited: 6
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions
Steven D. Forsythe, Tracey Pu, Stephen G. Andrews, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3756-3756
Open Access | Times Cited: 13
Advancements in Preclinical Models of Pancreatic Cancer
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5
Organoids in skin wound healing
Zitong Wang, Feng Zhao, Hongxin Lang, et al.
Burns & Trauma (2025) Vol. 13
Open Access
Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology
Jihao Xu, Minh Duc Pham, Vincenzo Corbo, et al.
Experimental & Molecular Medicine (2025)
Open Access
ATAC-seq as a versatile tool to portray genomes and epigenomes
Islem Toumi, Laurent Le Cam, Pierre‐François Roux
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients
Xiongfei Xu, Shiwei Guo, Haihui Gu, et al.
JCI Insight (2025) Vol. 10, Iss. 2
Open Access
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients
Xiaoyi Yin, Hui Shen, Huan Wang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups
Shunrong Ji, Lihua Cao, Jing Gao, et al.
Cancer Cell (2025)
Open Access
Pancreatic cancer subtyping - the keystone of precision treatment
Zeyang Fan, Yao Xiao, Yan Du, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top